Jump to content

Jab that will halt the most deadly forms of Cancer


Recommended Posts

Celldex Therapeutics Presents New Clinical Data from Phase 2 Study of CDX-011 in Metastatic Melanoma at 46th Annual ASCO Meeting

-Poster Presented on Study Design for Phase 2 Study of CDX-1307 in Bladder Cancer-

Mention of Pancreatic Cancer in paragraph headed ' About CDX-1307



Link to comment
Share on other sites

  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.